New colonoscopy standard launched at AGW for 2019

The new Colonoscopy Clinical Care Standard will go a long way to ensuring high quality and timely colonoscopies are available for the people who need them. Launched at Australian Gastroenterology Week 2018 in Brisbane by the Australian Commission on Safety...

The new Colonoscopy Clinical Care Standard will go a long way to ensuring high quality and timely colonoscopies are...

Research

Better tools required for non-responsive coeliac disease: Dr Jason Tye-Din

Use of gluten immunogenic peptide (GIP) assays to provide objective confirmation of gluten ingestion will be one way to improve management of the patient with non-responsive coeliac disease. Dr Jason Tye-Din, head of the Coeliac Research Lab at the Walter and...

Use of gluten immunogenic peptide (GIP) assays to provide objective confirmation of gluten ingestion will be one way to improve...

IBD

Professor Rupert Leong: patient preference should guide biologic choice

The decision about which biologic to choose for patients with Crohn’s disease used to be based largely on their preference for subcut or IV administration. And given the biologics and their biosimilars have similar rates of clinical remission, safety has become...

The decision about which biologic to choose for patients with Crohn’s disease used to be based largely on their preference...

IBD

Aim higher than “woefully inadequate” 30% remission in IBD

There have been some ‘heroic achievements’ in IBD but we are currently stuck with a therapeutic gap and the inability to arrest disease progression or prevent or cure IBD, AGW 2018 was told. Delivering the Bushell Lecture, Professor Severine Vermeire said...

There have been some ‘heroic achievements’ in IBD but we are currently stuck with a therapeutic gap and the inability...